Author

Huanling Zhang

Observed names: H Zhang, H. Zhang

Institutions: Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou Medical University

Observed institutions: Sun Yat-sen University, Nanfang Hospital, Guangzhou First People's Hospital, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Southern Medical University, South China University of Technology, Guangzhou Medical University

ORCID: 0009-0004-1194-1188

Observed ORCID: 0009-0004-1194-1188

OpenAlex ID: A5015502289

CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer

2016 · H Zhang, Y-L Ye, et al. · Oncogene · 279

A STING agonist potentiates C1 lipidoid-based mRNA cancer vaccine through promoting TNF-α secretion in vivo

2025 · Hongxia Zhang, Yang Lin, et al. · Molecular Therapy · 7

CBX2 suppresses interferon signaling to diminish tumor immunogenicity via a noncanonical corepressor complex

2025 · Yanxun Lin, Huan Jin, et al. · Proceedings of the National Academy of Sciences · 6

Pyrithione zinc alters mismatch repair to trigger tumor immunogenicity

2025 · Huanling Zhang, Jiaxin Wu, et al. · Oncogene · 3

Nuclear NAD + promotes innate immune memory by inhibiting KDM5A-dependent histone demethylation

2026 · Huan Jin, Zining Wang, et al. · Science Immunology · 1

The Role of Natural Compounds in Bladder Urothelial Carcinoma Treatment

2026 · Hangfei Jiang, Yueyin Chen, et al. · International Journal of Molecular Sciences · 1

CXCL2/MIF-CXCR2 signalling promotes the accumulation of myeloid-derived suppressor cells and correlates with a poor prognosis in bladder cancer

2016 · H. Zhang, Y.L. Ye, et al. · European Journal of Cancer · 1

Works count: 7

Citation count: 298

H-index: 3

I10-index: 1